Dingdang Quick Medicine Secures RMB 300 Million Series A Funding to Lead New Retail in Healthcare

Recently, significant news emerged from the pharmaceutical O2O sector: Dingdang Kuaiyao, which had previously maintained a “low-profile yet rapid-growth” strategy, officially announced that it has secured RMB 300 million in Series A financing from the renowned investment firm Tongdao Gongying. Launched on February 6, 2015, Dingdang Kuaiyao has undergone nearly two years of development. It has gained widespread recognition for its core service offering—free home delivery within 28 minutes in key areas—and has accumulated over ten million users, establishing itself as a leader in the pharmaceutical O2O industry.

In the current niche of internet-based pharmaceuticals, giants such as Alibaba and JD.com have entered the market alongside independent internet pharmaceutical startups. However, due to its direct impact on public health, the pharmaceutical industry possesses unique characteristics. By leveraging Renhe’s traditional resource advantages to drive an internet upgrade from the ground up, Dingdang Kuaiyao exemplifies the “Pharmaceuticals + Internet” model.

Since its inception, Dingdang Kuaiyao has been committed to building the “M2F + B2B + O2O” Dingdang Grand Health Ecosystem. By leveraging Renhe’s integration of industry resources, it has established the Heli IoT M2F model to address pain points faced by pharmaceutical manufacturers in traditional environments—such as fragmented upstream raw material procurement, high procurement costs, and complex procurement processes—thereby achieving economies of scale and significantly improving both pricing and operational efficiency.

Furthermore, by leveraging Renhe’s upstream resources—a direct supply network of health products from an alliance of 260 pharmaceutical manufacturers—Dingdang Kuaiyao is able to reduce costs through joint procurement and large-scale production at the upstream level. By minimizing intermediate distribution links, it creates room for price discounts for end users. The convenient and affordable access to medications has attracted tens of millions of users, generating substantial data assets. This big data, in turn, provides reverse guidance to the industrial side of production, enabling the delivery of products that truly meet user demands.

Senior industry insiders note that the unique characteristics of the pharmaceutical sector have inadvertently erected high entry barriers. Although the internet industry excels at driving user traffic, as the market deepens and expands, both tech giants entering the space and independent startups find themselves struggling to make headway. Currently, within the pharmaceutical O2O segment, only Dingdang Kuaiyao leverages the traditional centralized procurement resources of Renhe Pharmaceutical Group to build a comprehensive health ecosystem, representing the optimal “Pharmaceuticals + Internet” new retail model.

This November, Dingdang Kuaiyao announced that its daily order volume in the Beijing market had surpassed 20,000, making it the first to achieve profitability. It is understood that this makes Dingdang Kuaiyao the only profitable O2O medicine delivery platform in the pharmaceutical industry to date. This demonstrates that by leveraging the advantages of the Dingdang Big Health ecosystem and partnering with Renhe to integrate upstream and downstream segments of the industrial chain, Dingdang Kuaiyao has created a new model for ecosystem-based profitability. The recent RMB 300 million Series A financing round further indicates that investors recognize and endorse Dingdang Kuaiyao’s ecosystem-driven profitability model.

Within Dingdang Kuaiyao’s geofencing system, the coverage radius of pharmacies is five times that of traditional brick-and-mortar pharmacies. Leveraging Dingdang Kuaiyao’s geofencing technology and online user acquisition strategies, this model generates more orders for pharmacies. Additionally, Dingdang Kuaiyao provides professional training to pharmacy staff, enabling them to deliver free home delivery within 28 minutes.

Dingdang Kuaiyao has rapidly expanded by addressing the pain points of difficulty and high cost in purchasing medications, earning the trust of tens of millions of users. Currently, through its offline network operated by Dingdang Smart Pharmacy, it has achieved comprehensive coverage in seven major cities—Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu, Shenyang, and Zhengzhou—and provides free 24/7 delivery in core areas, delivering an exceptional user service experience.

Dingdang Kuaiyao Secures 300 Million in Funding to Build Its New Retail Model for Pharmaceutical and Healthcare Services

First, restructure online and offline resources. By empowering offline operations through Dingdang Kuaiyao, the service radius of stores is expanded, achieving a leap from 500 meters to 5 kilometers. Furthermore, by integrating online and offline resources via Dingdang Smart Pharmacy, the value of traditional pharmacies is reconstructed, empowering online services and enhancing user experience.

Second, deliver an exceptional user service experience. We will further deepen our 7/24, 28-minute home-based health services and strengthen our 24/7 pharmacist expert support.

Third, leverage member health big data. Dingdang Smart Pharmacy will establish electronic health records for users, collect health data, and create a “C2B” model to truly meet user needs.